Emerging Diseases News

ORLANDO, Fla. — A critical care nurse who served in a New York City ICU recounted how a commitment to lifelong learning helped her develop a treatment protocol that saved lives during the COVID-19 pandemic.

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

Ivory Coast administered the first doses of the world’s second malaria vaccine this week, according to the vaccine’s manufacturers, marking the latest development in a decades-long effort to control the deadly mosquito-borne disease.

The CDC said it has confirmed four new cases of highly pathogenic avian influenza in Colorado poultry workers and is aware of a fifth presumptive-positive case.

Children with presymptomatic type 1 diabetes progressed more quickly to type 1 diabetes after having COVID-19, according to a research letter published in JAMA.

The severity of a SARS-CoV-2 reinfection is likely to be similar to the severity of a patient’s initial infection, researchers found.

Socioeconomic disparities among residential neighborhoods may be associated with the prevalence of five specific antimicrobial-resistant organisms, especially AmpC beta-lactamase producers and methicillin resistant Staphylococcus aureus.

In the United States, the COVID-19 pandemic was associated with more than 50,000 lost electrophysiology procedures totaling more than $7 billion in revenue in 2020, researchers reported in HeartRhythm.

A first-in-human trial of a nasal COVID-19 vaccine candidate began enrolling adults aged 18 to 64 years who have received at least three prior doses of a COVID-19 messenger RNA vaccine, according to the NIH.

CHICAGO — Antioxidant therapies showed varying levels of effectiveness when used as a treatment for COVID-19, according to results of a recent systematic review and meta-analysis presented at NUTRITION.